MedPath

Indonesian Registry on Atrial Fibrillation

Conditions
Atrial Fibrillation
Registration Number
NCT04222868
Lead Sponsor
Indonesian Heart Rhythm Society
Brief Summary

Our rationale of creation of this registry stems from the fact that the use of VKA in patients with AF is a double-edged sword, physicians face tremendous burden in assigning patients with VKA, due to risk of Bleeding complications despite its potential benefit. We intend to seek a safe and beneficial range of INR on Indonesian patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Age >18 years old
  • Diagnosis of valvular or nonvalvular AF
Exclusion Criteria
  • Reversible AF
  • Patients who have been enrolled as a respondent on other clinical studies

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of Participants with Major Adverse Cardiovascular Events24 months

Major Adverse Cardiovascular Events including stroke/transient ischemic attack, thromboembolism, acute coronary syndrome

Number of Participants with Bleeding Events24 months

Intracranial bleeding, gastrointestinal bleeding

Mortality Rate24 months

All-cause Mortality

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (25)

RSUP dr. Kariadi

🇮🇩

Semarang, Jawa Tengah, Indonesia

RSUD dr. Saiful Anwar

🇮🇩

Malang, Jawa Timur, Indonesia

Rumah Sakit Umum Pusat Dr. M. Djamil

🇮🇩

Padang, Sumatera Barat, Indonesia

RS Hasan Sadikin Bandung

🇮🇩

Bandung, Indonesia

RS Mitra Keluarga Bekasi

🇮🇩

Bekasi, Indonesia

RS Cirebon

🇮🇩

CIrebon, Indonesia

RS Sanglah Denpasar

🇮🇩

Denpasar, Indonesia

RSUPN Dr.Cipto Mangunkusumo

🇮🇩

Jakarta, Indonesia

National Cardiovascular Center Harapan Kita

🇮🇩

Jakarta, Indonesia

RS Bina Waluya Jakarta

🇮🇩

Jakarta, Indonesia

Scroll for more (15 remaining)
RSUP dr. Kariadi
🇮🇩Semarang, Jawa Tengah, Indonesia
Pipin Ardhianto, MD
Contact
+62248442266
pipin_ardhianto@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.